US Dollar vs Yen

登録して、同じ考えを持つ投資家と議論するためのアクティブなフォーラムで相互作用するためのアクティブなフォーラムに参加してください。

登録

ZYME

Zymeworks (ZYME)

Zymeworks Inc

から:

Regulatory News

Text Search:

次の項目別のソート:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:ZYME

1 2 3 次へ >>

日付	受信時刻	ニュースソース	見出し	コード	企業名
2024/05/03	05 : 05	GlobeNewswire Inc.	Zymeworks Provides Corporate Update and Reports First Quarter 2024 Financial Results	NASDAQ:ZYME	Zymeworks Inc
2024/04/30	19 : 00	GlobeNewswire Inc.	Zymeworks Announces Participation in Upcoming Investor Conferences	NASDAQ:ZYME	Zymeworks Inc
2024/04/11	19 : 00	GlobeNewswire Inc.	Zymeworks To Report First Quarter 2024 Financial Results and Host Conference Call on May 2, 2024	NASDAQ:ZYME	Zymeworks Inc
2024/04/08	19 : 00	GlobeNewswire Inc.	Zymeworks Presents New Data from Multiple Preclinical Development Programs at 2024 American Association for Cancer Research Annual Meeting	NASDAQ:ZYME	Zymeworks Inc
2024/03/28	19 : 00	GlobeNewswire Inc.	Zymeworks Announces Appointment of Dr. Neil Gallagher to its Board of Directors	NASDAQ:ZYME	Zymeworks Inc
2024/03/27	19 : 00	GlobeNewswire Inc.	Zymeworks Announces Participation in Upcoming Investor Conferences	NASDAQ:ZYME	Zymeworks Inc
2024/03/08	06 : 46	Edgar (US Regulatory)	Form S-3ASR - Automatic shelf registration statement of securities of well-known seasoned issuers	NASDAQ:ZYME	Zymeworks Inc
2024/03/08	06 : 36	Edgar (US Regulatory)	Form RW - Registration Withdrawal Request	NASDAQ:ZYME	Zymeworks Inc
2024/03/07	07 : 25	Edgar (US Regulatory)	Form S-3 - Registration statement under Securities Act of 1933	NASDAQ:ZYME	Zymeworks Inc
2024/03/07	06 : 13	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:ZYME	Zymeworks Inc
2024/03/07	06 : 09	GlobeNewswire Inc.	Zymeworks Reports Fourth Quarter and Full Year 2023 Financial Results	NASDAQ:ZYME	Zymeworks Inc
2024/03/06	06 : 30	GlobeNewswire Inc.	Zymeworks to Present Preclinical Data on Antibody-Drug Conjugate and Multispecific Platforms at the American Association for Cancer Research Annual Meeting	NASDAQ:ZYME	Zymeworks Inc
2024/02/27	20 : 00	GlobeNewswire Inc.	Zymeworks Announces Participation in Upcoming Investor Conferences	NASDAQ:ZYME	Zymeworks Inc
2024/02/23	06 : 15	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:ZYME	Zymeworks Inc
2024/02/14	20 : 00	GlobeNewswire Inc.	Zymeworks To Host Fourth Quarter and Full Year 2023 Results Conference Call	NASDAQ:ZYME	Zymeworks Inc
2024/02/09	06 : 16	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:ZYME	Zymeworks Inc
2024/02/08	20 : 00	GlobeNewswire Inc.	Zymeworks Announces Appointment of Dr. Alessandra Cesano to its Board of Directors	NASDAQ:ZYME	Zymeworks Inc
2024/01/31	20 : 00	GlobeNewswire Inc.	Zymeworks Announces Participation in Upcoming Investor Conferences	NASDAQ:ZYME	Zymeworks Inc
2024/01/09	08 : 01	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:ZYME	Zymeworks Inc
2024/01/06	11 : 44	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:ZYME	Zymeworks Inc
2024/01/06	11 : 44	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:ZYME	Zymeworks Inc
2024/01/05	21 : 00	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:ZYME	Zymeworks Inc
2024/01/04	20 : 31	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:ZYME	Zymeworks Inc
2024/01/04	20 : 15	GlobeNewswire Inc.	Zymeworks Outlines Strategic Priorities and Outlook for 2024 and 2025	NASDAQ:ZYME	Zymeworks Inc
2024/01/04	20 : 00	GlobeNewswire Inc.	Zymeworks Announces Additional Leadership Appointments	NASDAQ:ZYME	Zymeworks Inc
2024/01/04	06 : 32	Edgar (US Regulatory)	Form D - Notice of Exempt Offering of Securities	NASDAQ:ZYME	Zymeworks Inc
2023/12/26	22 : 09	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:ZYME	Zymeworks Inc
2023/12/26	22 : 00	GlobeNewswire Inc.	Zymeworks Announces $50 Million Private Placement to EcoR1 Capital	NASDAQ:ZYME	Zymeworks Inc
2023/12/15	22 : 30	GlobeNewswire Inc.	Zymeworks Added to Nasdaq Biotechnology Index	NASDAQ:ZYME	Zymeworks Inc
2023/12/09	07 : 20	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:ZYME	Zymeworks Inc

Showing the most relevant articles for your search:NASDAQ:ZYME

1 2 3 次へ >>

Healthpeak Properties

First Citizens BancShares

First Oak Brook Bancshares

Columbia Banking System

Mercantile Bancorp

State Financial

Community Bancorp (QX)

Selina Hospitality

Delayed Upgrade Clock

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約